Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROMPT: Hypofractionated RT + Eligard in Prostate Cancer
NCT04249154Phase 2Recruiting
- Sponsor
- McGill University Health Centre
- Start
- Sep 2019
- Primary completion
- Dec 2026
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of leuprolide in prostate cancer (PCa), sponsored by McGill University Health Centre. Started Sep 2019; status: recruiting.
02
Drugs
leuprolide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT04249154.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04249154.